Review
doi: 10.1053/j.semtcvs.2010.09.007.
Vasoplegia during cardiac surgery: current concepts and management
Affiliations
- PMID: 21092891
- DOI: 10.1053/j.semtcvs.2010.09.007
Item in Clipboard
Review
Vasoplegia during cardiac surgery: current concepts and management
Semin Thorac Cardiovasc Surg.
2010 Summer.
Abstract
Vasoplegic syndrome (VS) is a recognized and relatively common complication of cardiopulmonary bypass (CPB), appearing with an incidence ranging between 5% and 25%. It is characterized by significant hypotension, high or normal cardiac outputs and low systemic vascular resistance (SVR), and increased requirements for fluids and vasopressors during or after CPB. Patients developing VS are at increased risk for death and other major complications following cardiac surgery. This review will focus on the pathophysiology and contemporary strategies of treating VS encountered after CPB.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
[Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].Rev Med Chil. 2011 Mar;139(3):368-72. Epub 2011 Aug 25. Rev Med Chil. 2011. PMID: 21879171 Review. Spanish.
-
A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.Interact Cardiovasc Thorac Surg. 2009 Oct;9(4):588-92. doi: 10.1510/icvts.2009.209890. Epub 2009 Jul 6. Interact Cardiovasc Thorac Surg. 2009. PMID: 19581293
-
Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment.Am J Med Sci. 2015 Jan;349(1):80-8. doi: 10.1097/MAJ.0000000000000341. Am J Med Sci. 2015. PMID: 25247756 Review.
-
Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.J Cardiothorac Vasc Anesth. 2018 Apr;32(2):1013-1022. doi: 10.1053/j.jvca.2017.10.032. Epub 2017 Oct 27. J Cardiothorac Vasc Anesth. 2018. PMID: 29223724 Review.
-
Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.Expert Rev Cardiovasc Ther. 2011 Dec;9(12):1519-25. doi: 10.1586/erc.11.160. Expert Rev Cardiovasc Ther. 2011. PMID: 22103871 Review.
Cited by
-
Rapid 500 mL albumin bolus versus rapid 200 mL bolus followed by slower continuous infusion in post-cardiac surgery patients: a pilot before-and-after study.Crit Care Resusc. 2023 Oct 18;23(3):320-328. doi: 10.51893/2021.3.OA9. eCollection 2021 Sep 6. Crit Care Resusc. 2023. PMID: 38046079 Free PMC article.
-
Peroxynitrite decomposition catalyst reduces vasopressin requirement in ovine MRSA sepsis.Intensive Care Med Exp. 2019 Sep 9;7(1):12. doi: 10.1186/s40635-019-0227-4. Intensive Care Med Exp. 2019. PMID: 31512009 Free PMC article.
-
Use of methylene blue in vasoplegic syndrome that developed during non-cardiac surgery - A case report.Anesth Pain Med (Seoul). 2019 Oct 31;14(4):460-464. doi: 10.17085/apm.2019.14.4.460. Anesth Pain Med (Seoul). 2019. PMID: 33329778 Free PMC article.
-
2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.Br J Anaesth. 2025 Apr;134(4):917-1008. doi: 10.1016/j.bja.2025.01.015. Epub 2025 Feb 14. Br J Anaesth. 2025. PMID: 39955230 Free PMC article.
-
The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.Cardiovasc Drugs Ther. 2022 Aug;36(4):739-748. doi: 10.1007/s10557-020-07098-3. Epub 2020 Oct 21. Cardiovasc Drugs Ther. 2022. PMID: 33085026 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
